Seizure Susceptibility and Mortality in Mice That Over-express Amyloid Precursor Protein

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2008 Sep 12

PMID 18784809

Citations 55

Authors

Cara J Westmark

Pamela R Westmark

Ashley M Beard

Sharon M Hildebrandt

James S Malter

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease and Fragile X syndrome both display synaptic phenotypes, and based on recent studies, likely share dendritic over expression of amyloid precursor protein (APP) and beta-amyloid (Abeta). In order to create a mouse model to specifically study the effects of APP and Abeta at synapses, we crossed Tg2576, which over-express human APP with the Swedish mutation (hAPPsw), with fmr-1 KO mice. The progeny, named FRAXAD, displayed increased mortality (23% by 30 days of age) compared to Tg2576 (3%) and WT and fmr-1 KO littermate controls (0%) consistent with a developmental defect. By 60 days of age, both the Tg2576 and FRAXAD mice approached a 40% mortality rate compared to 0% for WT and fmr-1 KO littermates. To understand the mechanism underlying increased mortality in APP over-expressing mice, we assessed seizure thresholds in response to pentylenetetrazol (PTZ). Both the Tg2576 and FRAXAD mice had a lower threshold to PTZ-induced seizures (average seizure score of >/=4.0) in comparison to nontransgenic littermates (average seizure score 1.9-2.9). Seizures are a major phenotype of AD, FXS, Down syndrome, autism and epilepsy, and these data suggested that developmental over-expression of dendritic APP or Abeta increased seizure susceptibility.

Citing Articles

Exploring the mechanism of action of Phyllanthus emblica in the treatment of epilepsy based on network pharmacology and molecular docking.

Xiao L, Chen W, Guo W, Li H, Chen R, Chen Q Medicine (Baltimore). 2025; 104(7):e41414.

PMID: 39960946 PMC: 11835119. DOI: 10.1097/MD.0000000000041414.

Epileptic seizures induced by pentylenetetrazole kindling accelerate Alzheimer-like neuropathology in 5×FAD mice.

Zou Y, Wang C, Li H, Zhong M, Lin J, Hu Y Front Pharmacol. 2024; 15:1500105.

PMID: 39545066 PMC: 11560768. DOI: 10.3389/fphar.2024.1500105.

Seizures exacerbate excitatory: inhibitory imbalance in Alzheimer's disease and 5XFAD mice.

Barbour A, Gourmaud S, Lancaster E, Li X, Stewart D, Hoag K Brain. 2024; 147(6):2169-2184.

PMID: 38662500 PMC: 11146435. DOI: 10.1093/brain/awae126.

Protection by Nano-Encapsulated Bacoside A and Bacopaside I in Seizure Alleviation and Improvement in Sleep- In Vitro and In Vivo Evidences.

C Sekhar V, Gulia K, Deepti A, Baby Chakrapani P, Baby S, Viswanathan G Mol Neurobiol. 2023; 61(6):3296-3313.

PMID: 37987958 DOI: 10.1007/s12035-023-03741-w.

Bace1 Deletion in the Adult Reverses Epileptiform Activity and Sleep-wake Disturbances in AD Mice.

Yao A, Halloran P, Ge Y, Singh N, Zhou J, Galske J J Neurosci. 2023; 43(35):6197-6211.

PMID: 37536983 PMC: 10476643. DOI: 10.1523/JNEUROSCI.2124-22.2023.

References

Huang R, Bell-Horner C, Dibas M, Covey D, Drewe J, Dillon G . Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action. J Pharmacol Exp Ther. 2001; 298(3):986-95. View

Herard A, Besret L, Dubois A, Dauguet J, Delzescaux T, Hantraye P . siRNA targeted against amyloid precursor protein impairs synaptic activity in vivo. Neurobiol Aging. 2005; 27(12):1740-50. DOI: 10.1016/j.neurobiolaging.2005.10.020. View

Kamatchi G, Kofuji P, Wang J, Fernando J, Liu Z, Mathura Jr J . GABAA receptor beta 1, beta 2, and beta 3 subunits: comparisons in DBA/2J and C57BL/6J mice. Biochim Biophys Acta. 1995; 1261(1):134-42. DOI: 10.1016/0167-4781(95)00009-6. View

Velez L, Selwa L . Seizure disorders in the elderly. Am Fam Physician. 2003; 67(2):325-32. View

Westmark C, Malter J . FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol. 2007; 5(3):e52. PMC: 1808499. DOI: 10.1371/journal.pbio.0050052. View

Menendez M . Down syndrome, Alzheimer's disease and seizures. Brain Dev. 2005; 27(4):246-52. DOI: 10.1016/j.braindev.2004.07.008. View

Peier A, McIlwain K, Kenneson A, Warren S, Paylor R, Nelson D . (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. Hum Mol Genet. 2000; 9(8):1145-59. DOI: 10.1093/hmg/9.8.1145. View

Mucke L, Masliah E, Johnson W, Ruppe M, Alford M, Rockenstein E . Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice. Brain Res. 1994; 666(2):151-67. DOI: 10.1016/0006-8993(94)90767-6. View

Lyckman A, Confaloni A, Thinakaran G, Sisodia S, Moya K . Post-translational processing and turnover kinetics of presynaptically targeted amyloid precursor superfamily proteins in the central nervous system. J Biol Chem. 1998; 273(18):11100-6. DOI: 10.1074/jbc.273.18.11100. View

10.

Mattson M, Barger S, Cheng B, Lieberburg I, Rydel R . beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Trends Neurosci. 1993; 16(10):409-14. DOI: 10.1016/0166-2236(93)90009-b. View

11.

Hung A, Koo E, Haass C, Selkoe D . Increased expression of beta-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage. Proc Natl Acad Sci U S A. 1992; 89(20):9439-43. PMC: 50147. DOI: 10.1073/pnas.89.20.9439. View

12.

Kim T, Wu K, Xu J, McAuliffe G, Tanzi R, Wasco W . Selective localization of amyloid precursor-like protein 1 in the cerebral cortex postsynaptic density. Brain Res Mol Brain Res. 1995; 32(1):36-44. DOI: 10.1016/0169-328x(95)00328-p. View

13.

Soba P, Eggert S, Wagner K, Zentgraf H, Siehl K, Kreger S . Homo- and heterodimerization of APP family members promotes intercellular adhesion. EMBO J. 2005; 24(20):3624-34. PMC: 1276707. DOI: 10.1038/sj.emboj.7600824. View

14.

DAgata V, Warren S, Zhao W, Torre E, Alkon D, Cavallaro S . Gene expression profiles in a transgenic animal model of fragile X syndrome. Neurobiol Dis. 2002; 10(3):211-8. DOI: 10.1006/nbdi.2002.0506. View

15.

Chen L, Toth M . Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience. 2001; 103(4):1043-50. DOI: 10.1016/s0306-4522(01)00036-7. View

16.

Kobayashi D, Zeller M, Cole T, Buttini M, McConlogue L, Sinha S . BACE1 gene deletion: impact on behavioral function in a model of Alzheimer's disease. Neurobiol Aging. 2007; 29(6):861-73. DOI: 10.1016/j.neurobiolaging.2007.01.002. View

17.

Doyle E, Bruce M, Breen K, Smith D, Anderton B, Regan C . Intraventricular infusions of antibodies to amyloid-beta-protein precursor impair the acquisition of a passive avoidance response in the rat. Neurosci Lett. 1990; 115(1):97-102. DOI: 10.1016/0304-3940(90)90524-d. View

18.

Torroja L, Packard M, GORCZYCA M, White K, Budnik V . The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J Neurosci. 1999; 19(18):7793-803. PMC: 6782486. View

19.

Steinbach J, Muller U, Leist M, Li Z, Nicotera P, Aguzzi A . Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice. Cell Death Differ. 1999; 5(10):858-66. DOI: 10.1038/sj.cdd.4400391. View

20.

Musumeci S, Bosco P, Calabrese G, Bakker C, De Sarro G, Elia M . Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia. 2000; 41(1):19-23. DOI: 10.1111/j.1528-1157.2000.tb01499.x. View